Elecsys® Vitamin D total II

Allowing better patient care with results you can trust

Elecsys® Vitamin D total II

Allowing better patient care with results you can trust

Vitamin D has a proven impact on bone mineral density and bone quality. Desirable levels of 30 ng/mL have been shown to ­reduce the risk of falls and fractures.

There is also growing scientific evidence linking vitamin D (25-OH) to muscle health and other indications such as diabetes, cardiovascular diseases, autoimmune diseases, respiratory diseases and cancer. The Elecsys Vitamin D total II assay aids in the assessment of vitamin D sufficiency.

 

Benefits

 

  • Direct traceability to the official reference measurement procedure (Ghent University ID-LC-MS/MS) for confidence in ­patient results
  • Center of Disease Control certification as a proof source of accuracy in patient results
  • High lot-to-lot consistency for optimal therapy monitoring
  • Excellent sensitivity and precision over the clinically relevant range
  • Efficiency due to consolidation of Vitamin D total, b-CrossLaps, P1NP, Osteocalcin and PTH testing on one fully automated platform

Elecsys® Vitamin D total II

  • Assay time

    27 min

  • Sample material

    Serum and plasma

  • Sample volume

    12 µL

  • Limit of quantitation

    ≤5 ng/mL (≤12.5 nmol/L)

  • Repeatability

    <20 ng/mL SD ≤1.1 ng/mL; >20 ng/mL CV ≤5.5 %

  • Intermediate precision

    <20 ng/mL SD ≤1.4 ng/mL; >20 ng/mL CV ≤7.0 %